Form D · Other Health Care
NEUROLYTIC HEALTHCARE, INC.
London, X0 · CIK 0001901484
Offering snapshot reported Dec 29, 2021 · SEC filing
- Reported sold
- $3.08M Indefinite offering
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 14, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 29, 2021 | Initial | $3,081,917 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-427025
Source: Form D, filed Dec 29, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tom Kent | Director, Executive, Promoter |
| Roman Rothaermel | Director, Executive, Promoter |
| Parul Singh | Director |
| Inna Thalmann | Director, Executive, Promoter |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
78 Cannon Street, Cannon Place
London, X0, EC4N 6AF
London, X0, EC4N 6AF